PLK1 and hepatocellular carcinoma: Nanocapsules can be adapted to insert the Cas9 ribonucleoprotein/sgRNA complex targeting other tumor‐associated genes, such as the apoptosis genes P53 and PLK1, as well as the angiogenesis gene VEGF, into HCC cells.[50, 51, 52]